Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (20)

1

Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies : results from a systematic review and meta-analysis of randomized controlled trial

enthalten in: International journal of clinical oncology | 2018

von Zhu, J. | Zhao, W. | Liang, D. | +4

2

Correlation of cetuximab-induced skin rash and outcomes of solid tumor patients treated with cetuximab : a systematic review and meta-analysis

enthalten in: Critical reviews in oncology/hematology | 2015

von Abdel-Rahman, O. | Fouad, M.

3

Cetuximab in head and neck squamous cell carcinoma : a systematic review and Meta-analysis

enthalten in: Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery | 2015

von Song, Q. | Li, X. | Li, B.

4

Infectious complications in cancer patients treated with anti-EGFR monoclonal antibodies cetuximab and panitumumab : a systematic review and meta-analysis

enthalten in: Cancer treatment reviews | 2014

von Funakoshi, T. | Suzuki, M. | Tamura, K.

5

KRAS mutation testing of tumours in adults with metastatic colorectal cancer : a systematic review and cost-effectiveness analysis

enthalten in: Health technology assessment (Winchester, England) | 2014

von Westwood, M. | van Asselt, T. | Ramaekers, B. | +7

6

Does the addition of targeted biological agents to first-line chemotherapy for advanced colorectal cancer increase complete response? A systematic review and meta-analysis

enthalten in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland | 2014

von Qi, W. | Shen, Z. | Tang, L. | +1

7

The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer : A systematic review and meta-analysis

enthalten in: Acta oncologica (Stockholm, Sweden) | 2014

von Therkildsen, C. | Bergmann, T. | Henrichsen-Schnack, T. | +2

CommentIn: Acta Oncol. 2014 Jul;53(7):849-51. - PMID 24954366

8

Concomitant platinum-based chemotherapy or cetuximab with radiotherapy for locally advanced head and neck cancer : a systematic review and meta-analysis of published studies

enthalten in: Oral oncology | 2014

von Petrelli, F. | Coinu, A. | Riboldi, V. | +6

9

The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No.150 and part review of technology appraisal No. 118) : a systematic review and economic model

enthalten in: Health technology assessment (Winchester, England) | 2013

von Hoyle, M. | Crathorne, L. | Peters, J. | +5

10

KRAS p.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer : a systematic review and meta-analysis

enthalten in: Cancer | 2013

von Mao, C. | Huang, Y. | Yang, Z. | +3